首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1136936

儿童用抗生素市场:感染疾病，各给药途径，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年08月29日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3个工作天内

价格

简介目录

市场动态

全球儿科抗生素市场的主要参与者正专注于采用产品批准等增长战略，预计这将在预测期内推动市场增长。

本调查的主要特征

本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球儿童用抗生素市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球儿童用抗生素市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球儿童用抗生素市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球儿童用抗生素市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

热图分析
市场占有率分析
- Johnson & Johnson
- Astellas Pharma, Inc.
- Pfizer Inc.,
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc.
- Aurobindo Pharma USA
- GlaxoSmithKline Plc.,
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.

第10章章节

调查手法的介绍
关于出版社

简介目录

Product Code: CMI5190

Antibiotics are used to treat or prevent some types of bacterial infection. Antibiotics work by killing bacteria or preventing them from reproducing and spreading. Antibiotics are the most commonly prescribed drugs in children and have the potential to save the lives of patients with severe bacterial infections such as Non-Specific Upper Respiratory Tract Infections, Urinary Tract Infections etc. They are taken orally and come in the form of tablets, liquid suspension, and capsules. Antibiotics are also administered through the intravenous route. Antibiotics are available in the form of ointments, creams, lotions, etc. for topical administration.

Market Dynamics

Key players operating in the global pediatric antibiotics market are focusing on adoption of growth strategies such as product approval, which is expected to drive market growth during the forecast period. For instance, in January 2020, Merck a leading global biopharmaceutical company known as MSD outside of the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older. Moreover, increasing demand of pediatric antibiotics is expected to propel market growth over the forecast period. For instance, in 2021, United Nations International Children's Emergency Fund (UNICEF) delivered 31.6 million antibiotic treatments to children under one year of age in 54 countries.

Key features of the study:

This report provides in-depth analysis of the global pediatric antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pediatric antibiotics market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy's Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pediatric antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric antibiotics market.

Detailed Segmentation:

Global Pediatric antibiotics Market, By Infection :
- Acute Sinusitis
- Acute Otitis Media
- Non-Specific Upper Respiratory Tract Infections
- Urinary Tract Infections
- Others
Global Pediatric antibiotics Market, By Route of Administration :
- Oral
- Topical
- Intravenous
- Others
Global Pediatric antibiotics Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
Global Pediatric antibiotics Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Johnson & Johnson.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma, Inc,
- Pfizer Inc
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Dr. Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc
- Aurobindo Pharma USA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals PLC
- Cipla Inc
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd., etc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Infection
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Treatment Algorithm

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Acute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Acute Otitis Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Non-Specific Upper Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Astellas Pharma, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer Inc.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Abbott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- DAIICHI SANKYO COMPANY, LIMITED
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Reddy's Laboratories Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceuticals USA, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Aurobindo Pharma USA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GlaxoSmithKline Plc.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Cipla Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Glenmark Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Torrent Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

儿童用抗生素市场:感染疾病，各给药途径，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章调查目的与前提条件

第2章市场展望

第3章市场动态，法规，及趋势的分析

第4章儿童用抗生素的全球市场-冠状病毒(COVID-19)疫情的影响

第5章儿童用抗生素的全球市场，感染疾病，2017-2030年

第6章儿童用抗生素的全球市场(各给药途径):2017年～2030年

第7章儿童用抗生素的全球市场(各流通管道):2017年～2030年

第8章儿童用抗生素的全球市场:各地区，2017-2030年

第9章竞争情形

第10章章节

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

儿童用抗生素市场:感染疾病，各给药途径，各流通管道，各地区- 规模，占有率，展望，机会分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市场动态

本调查的主要特征

目录

第1章 调查目的与前提条件

第2章 市场展望

第3章 市场动态，法规，及趋势的分析

第4章 儿童用抗生素的全球市场-冠状病毒(COVID-19)疫情的影响

第5章 儿童用抗生素的全球市场，感染疾病，2017-2030年

第6章 儿童用抗生素的全球市场(各给药途径):2017年～2030年

第7章 儿童用抗生素的全球市场(各流通管道):2017年～2030年

第8章 儿童用抗生素的全球市场:各地区，2017-2030年

第9章 竞争情形

第10章 章节

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章调查目的与前提条件

第2章市场展望

第3章市场动态，法规，及趋势的分析

第4章儿童用抗生素的全球市场-冠状病毒(COVID-19)疫情的影响

第5章儿童用抗生素的全球市场，感染疾病，2017-2030年

第6章儿童用抗生素的全球市场(各给药途径):2017年～2030年

第7章儿童用抗生素的全球市场(各流通管道):2017年～2030年

第8章儿童用抗生素的全球市场:各地区，2017-2030年

第9章竞争情形

第10章章节